Overseas giants are betting big on AI healthcare, Global X China MedTech ETF (02841.HK) once surging over 3%! Constituent stock Ali Health leads the gains
According to NewTimeSpace reports, Wind data shows that as of 14:45 on January 14, 2026,Global X China MedTech ETF (02841.HK) rose by 2.51%, with an intraday increase once exceeding 3%. Among its constituent stocks, Ali Health performed brilliantly, once surging over 20% in the afternoon.
In terms of news, at the 44th JPMorgan Chase (JPM) Global Healthcare Conference recently, NVIDIA and Eli Lilly announced that they will invest 1 billion US dollars over the next five years to build a joint research laboratory in the San Francisco Bay Area, aiming to accelerate the application of artificial intelligence in the pharmaceutical industry. The subsequent cooperation between the two parties will focus on building a continuous learning system that closely connects Eli Lilly's intelligent wet laboratories with computational dry laboratories, thereby realizing round-the-clock AI-assisted experiments to support biologists and chemists.
Global X China MedTech ETF (02841.HK) is an exchange-traded fund (ETF) launched by Global X, tracking the Solactive China Healthcare Technology Index. It focuses on healthcare technology companies listed in Mainland China and Hong Kong, covering segments such as medical devices, digital healthcare, and biopharmaceuticals.
China Post Securities pointed out that the expected high growth in performance of overseas AI healthcare companies and the continuous increase in investment by leading global companies in the industry are expected to reflect the future performance expectations of domestic similar companies. The "AI + healthcare" market is expected to exceed 100 billion US dollars, with significant advantages over traditional pharmaceutical research and development. It builds a moat through the closed loop of algorithms + data + clinical scenarios, and the sector enjoys a valuation premium.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
